Újdonságok és tapasztalatok a krónikus mieloid leukémia tirozinkináz-gátló kezelésében

Translated title of the contribution: Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia

Júlia Gaál-Weisinger, Orsolya Mucsi, Gábor Körösmezey, Balázs Szili, Hanna Eid, Richárd Kiss, Csaba Bödör, Ilona Tárkányi, Zsolt Nagy, J. Demeter

Research output: Contribution to journalArticle

Abstract

The introduction of tyrosine kinase inhibitor (TKI) treatment has resulted in dramatically improved survival in chronic myeloid leukemia (CML). With the new generation of TKIs the majority of patients reach optimal molecular response. Due to the improving survival and the need for lifelong treatment, the safety profile of the various TKIs and the comorbidities of patients have to be considered. More than half of our CML patients had comorbidities that could have influenced the choice of therapy. Because of the high prevalence of cardiovascular comorbidities, cardiovascular risk assessment plays an important role in the care of CML patients. The aim of this article is to summarize the current national and international guidelines of the treatment in CML and to show the importance of comorbidities and cardiovascular risk assessment in our CML patients.

Translated title of the contributionNovelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia
Original languageHungarian
Pages (from-to)67-74
Number of pages8
JournalMagyar onkologia
Volume61
Issue number1
Publication statusPublished - Mar 8 2017

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Novelties and experience with tyrosine kinase inhibitor therapy in chronic myeloid leukemia'. Together they form a unique fingerprint.

  • Cite this

    Gaál-Weisinger, J., Mucsi, O., Körösmezey, G., Szili, B., Eid, H., Kiss, R., Bödör, C., Tárkányi, I., Nagy, Z., & Demeter, J. (2017). Újdonságok és tapasztalatok a krónikus mieloid leukémia tirozinkináz-gátló kezelésében. Magyar onkologia, 61(1), 67-74.